Merck, Daiichi Sankyo withdraw US application for lung cancer therapy

Merck NYSE:MRK and Daiichi Sankyo TSE:4568 have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the companies said on Friday.The decision followed discussions with the US Food and Drug Administration, which determined that the data…